Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease

Ophthalmology

Volumn 103, Issue 5, 1996, Pages 768-775

  Tamesis, R R ^a   Rodriguez, A ^a   Christen, W G ^a   Akova, Y A ^a   Messmer, E ^a   Foster, C S ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ADULT; AGE; ARTICLE; BLOOD TOXICITY; DRUG TOXICITY; ENDOCRINE DISEASE; EYE INFLAMMATION; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PATHOLOGIC FRACTURE; PRIORITY JOURNAL;

EID: 0029993616     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(96)30618-0     Document Type: Article

References (41)

1. DM Gordon Hydrocortisone in ophthalmology Am J Ophthalmol 37 1954 533 538
2. DM Gordon Prednisone and prednisolone in ocular disease Am J Ophthalmol 41 1956 593 600
3. J Santamaria II Steroidal agents: their systemic and ocular complications Ocular Inflammation and Therapeutics 1 1983 19 26
4. AS Fauci BF Haynes P Katz SM Wolff Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 98 1983 76 85
5. RB Nussenblatt AG Palestine CC Chan Effectiveness of cyclosporine therapy for Behcet's disease Arthritis Rheum 28 1985 671 679
6. JH Elliott WH Ballinger Behcet's syndrome: treatment with chlorambucil Trans Am Ophthalmol Soc 82 1984 264 281
7. RF Willkens Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis Semin Arthritis Rheum 20 1990 76 80
8. RJ McKendry M Cyr Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients Arch Intern Med 149 1989 685 689
9. G Singh JF Fries P Spitz CA Williams Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective Arthritis Rheum 32 1989 837 843
10. CS Foster Immunosuppressive therapy for external ocular inflammatory disease Ophthalmology 87 1980 140 150
11. CS Foster LA Wilson MB Ekins Immunosuppressive therapy for progressive ocular cicatricial pemphigoid Ophthalmology 89 1982 340 353
12. CS Foster SL Forstot LA Wilson Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression Ophthalmology 91 1984 1253 1263
13. TP Thomas The complications of systemic corticosteroid therapy in the elderly. A retrospective study Gerontology 30 1984 60 65
14. DS David MH Grieco P Cushman Jr Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences J Chronic Dis 22 1970 637 711
15. DC Dale RG Petersdorf Corticosteroids and infectious diseases Med Clin North Am 57 1973 1277 1287
16. P Chamberlin WJ Meyer III Management of pituitary-adrenal suppression secondary to corticosteroid therapy Pediatrics 67 1981 245 251
17. OS Gluck WA Murphy TJ Hahn B Hahn Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy Arthritis Rheum 24 1981 892 898
18. JM Richards SM Santiago WB Klaustermeyer Aseptic necrosis of the femoral head in corticosteroid-treated pulmonary disease Arch Intern Med 140 1980 1473 1475
19. JF Mahony AGR Sheil SB Etheredge Delayed complications of renal transplantation and their prevention Med J Aust 2 1982 426 429
20. ME Weinblatt Toxicity of low dose methotrexate in rheumatoid arthritis J Rheumatol 12 Suppl 12 1985 35 39
21. JK Whisnant J Pelkey Rheumatoid arthritis: treatment with azathioprine (IMURAN[R]). Clinical side-effects and laboratory abnormalities Ann Rheum Dis 41 Suppl 1 1982 44 47
22. LA Levine JP Richie Urological complications of cyclophosphamide J Urol 141 1989 1063 1069
23. BD Kahan Cyclosporine N Engl J Med 321 1989 1725 1738
24. RA Luqmani RG Palmer PA Bacon Azathioprine, cyclophosphamide and chlorambucil Baillieres Clin Rheumatol 4 1990 595 619
25. RL DeGowin A review of therapeutic and hemolytic effects of dapsone Arch Intern Med 120 1967 242 248
26. PG Lang Jr Sulfones and sulfonamides in dermatology today J Am Acad Dermatol 1 1979 479 492
27. GB Klintmalm S Iwatsuki TE Starzl Nephrotoxicity of cyclosporin A in liver and kidney transplant patients Lancet 1 8218 1981 470 471
28. AG Palestine HA Austin RB Nussenblatt Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis Transplant Proc 17 4 Suppl 1 1985 209 214
29. RL Black WM O'Brien EJ Van Scott Methotrexate therapy in psoriatic arthritis. Double-blind study on 21 patients JAMA 189 10 1964 743 747
30. J Colsky EM Greenspan TN Warren Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists AMA Arch Pathol 59 1955 198 206
31. H Zachariae K Kragballe H Sogaard Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment Br J Dermatol 102 1980 407 412
32. JK Robinson RD Baughman R Auerbach RJ Cimis Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals Arch Dermatol 116 1980 413 415
33. JF Fries Advances in management of rheumatic disease. 1965 to 1985 Arch Intern Med 149 1989 1002 1011
34. EV Hess ME Luggen Remodeling the pyramid-a concept whose time has not yet come [editorial] J Rheumatol 16 1989 1175 1176
35. H Hamdy RJR McKendry E Mierins JA Liver Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial Arthritis Rheum 30 1987 361 368
36. J Aponte M Petrelli Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate Arthritis Rheum 31 1988 1457 1464
37. WJ Shergy RP Polisson DS Caldwell Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis Am J Med 85 1988 771 774
38. RF Willkens PA Leonard DO Clegg Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis Ann Rheum Dis 49 1990 591 593
39. JM Kremer RG Lee KG Tolman Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples Arthritis Rheum 32 1989 121 127
40. B Amor C Mery Chlorambucil in rheumatoid arthritis Clin Rheum Dis 6 1980 567 584
41. R Hemady J Tauber CS Foster Immunosuppressive drugs in immune and inflammatory ocular disease [published erratum appears in Surv Ophthalmol 1991 May-June; 35:475] Surv Ophthalmol 35 1991 369 385